Itraconazole in chronic pulmonary aspergillosis: In whom, for how long, and at what dose?
作者信息
Maturu Venkata Nagarjuna, Agarwal Ritesh
机构信息
Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, Haryana and Punjab, India E-mail:
出版信息
Lung India. 2015 Jul-Aug;32(4):309-12. doi: 10.4103/0970-2113.159523.
Abstract
摘要
相似文献
1
Itraconazole in chronic pulmonary aspergillosis: In whom, for how long, and at what dose?
Lung India. 2015 Jul-Aug;32(4):309-12. doi: 10.4103/0970-2113.159523.
2
[An open, noncomparative multicenter study of the efficacy and safety of itraconazole injections and high dose capsules in chronic pulmonary aspergillosis].
Kansenshogaku Zasshi. 2011 Nov;85(6):644-51. doi: 10.11150/kansenshogakuzasshi.85.644.
3
Itraconazole therapy in aspergillosis: study in 49 patients.
J Am Acad Dermatol. 1990 Sep;23(3 Pt 2):607-14. doi: 10.1016/0190-9622(90)70263-h.
4
Effect of a 150 mg dose of rifabutin on serum itraconazole levels in patients with coexisting chronic pulmonary aspergillosis and Mycobacterium avium complex lung disease.
J Infect Chemother. 2017 Sep;23(9):658-660. doi: 10.1016/j.jiac.2017.02.004. Epub 2017 Mar 8.
5
Chronic invasive sinus and intracerebral aspergillosis controlled by combination therapy with micafungin and a daily dose of 400 mg itraconazole oral solution.
J Infect Chemother. 2015 Feb;21(2):134-7. doi: 10.1016/j.jiac.2014.08.010. Epub 2014 Oct 16.
6
[Two cases of pulmonary aspergillosis successfully treated with combinated micafungin and itraconazole therapy].
Kansenshogaku Zasshi. 2005 Dec;79(12):951-6. doi: 10.11150/kansenshogakuzasshi1970.79.951.
7
Treatment of cerebral Aspergillosis with itraconazole: do high doses improve the prognosis?
Clin Infect Dis. 1995 Dec;21(6):1485-7. doi: 10.1093/clinids/21.6.1485.
8
[Pulmonary aspergillosis complicating chronic septic granulomatosis. Treatment with itraconazole and gamma interferon].
Rev Mal Respir. 2000 Nov;17(5):975-8.
9
[Diagnosis and treatment of chronic pulmonary aspergillosis in 4 children].
Zhonghua Er Ke Za Zhi. 2005 Feb;43(2):113-7.
10
Efficacy and safety of short- and long-term treatment of itraconazole on chronic necrotizing pulmonary aspergillosis in multicenter study.
J Infect Chemother. 2012 Jun;18(3):378-85. doi: 10.1007/s10156-012-0414-7. Epub 2012 Apr 24.
引用本文的文献
1
High altitude pulmonary edema at 2640 m altitude associated with an acute Rhinovirus infection. First case in the literature.
Respir Med Case Rep. 2022 Dec 9;41:101791. doi: 10.1016/j.rmcr.2022.101791. eCollection 2023.
2
Molecular Characterization and Antifungal Susceptibility of spp. among Patients with Underlying Lung Diseases.
Trop Med Infect Dis. 2022 Sep 28;7(10):274. doi: 10.3390/tropicalmed7100274.
3
Surgical management of pulmonary aspergilloma-12 years' experience from a tertiary care centre in India.
Indian J Thorac Cardiovasc Surg. 2021 Jul;37(4):402-410. doi: 10.1007/s12055-021-01181-6. Epub 2021 May 10.
4
Idiopathic pulmonary fibrosis with chronic necrotizing pulmonary aspergillosis: a case report.
Int J Clin Exp Pathol. 2019 Jul 1;12(7):2653-2656. eCollection 2019.
5
Widespread amphotericin B-resistant strains of in Hamilton, Canada.
Infect Drug Resist. 2018 Sep 20;11:1549-1555. doi: 10.2147/IDR.S170952. eCollection 2018.
6
Strengthening the One Health Agenda: The Role of Molecular Epidemiology in Threat Management.
Genes (Basel). 2018 Jul 19;9(7):359. doi: 10.3390/genes9070359.
本文引用的文献
1
A comparative study of itraconazole in various dose schedules in the treatment of pulmonary aspergilloma in treated patients of pulmonary tuberculosis.
Lung India. 2015 Jul-Aug;32(4):342-6. doi: 10.4103/0970-2113.159563.
2
Estimation of the burden of chronic and allergic pulmonary aspergillosis in India.
PLoS One. 2014 Dec 5;9(12):e114745. doi: 10.1371/journal.pone.0114745. eCollection 2014.
3
Diagnosis and treatment of pulmonary aspergillosis syndromes.
Chest. 2014 Nov;146(5):1358-1368. doi: 10.1378/chest.14-0917.
4
The clinical spectrum of pulmonary aspergillosis.
Thorax. 2015 Mar;70(3):270-7. doi: 10.1136/thoraxjnl-2014-206291. Epub 2014 Oct 29.
5
Chronic pulmonary aspergillosis: an update on diagnosis and treatment.
Respiration. 2014;88(2):162-74. doi: 10.1159/000362674. Epub 2014 Jun 17.
6
Prevalence of Aspergillus sensitisation in pulmonary tuberculosis-related fibrocavitary disease.
Int J Tuberc Lung Dis. 2014 Jul;18(7):850-5. doi: 10.5588/ijtld.13.0838.
7
Recurrence of chronic pulmonary aspergillosis after discontinuation of maintenance treatment by antifungal triazoles.
J Infect Chemother. 2014 Jun;20(6):375-9. doi: 10.1016/j.jiac.2014.02.003. Epub 2014 Mar 26.
8
Chronic pulmonary aspergillosis.
Mycoses. 2014 May;57(5):257-70. doi: 10.1111/myc.12152. Epub 2013 Dec 2.
9
Azole resistance in Aspergillus fumigatus: a growing public health concern.
Curr Opin Infect Dis. 2013 Dec;26(6):493-500. doi: 10.1097/QCO.0000000000000005.
10
Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria.
Clin Exp Allergy. 2013 Aug;43(8):850-73. doi: 10.1111/cea.12141.
Zotero 插件